AWM Investment Company Inc. Acquires New Shares in CryoPort, Inc. $CYRX

Key Points

• AWM Investment Company acquired 61,111 CryoPort shares worth approximately $959,000, giving it a 0.12% stake. Institutional investors collectively own 92.9% of the company.
• CryoPort shares rose 2.3% to $16.72, near their 52-week high, despite the company reporting a quarterly EPS loss of $0.20 and negative net margins. Revenue of $48.97 million exceeded analyst expectations.
• Analyst sentiment remains generally positive, with seven Buy ratings and an average price target of $18.00, although insiders sold 256,441 shares worth about $4.05 million over the past 90 days.

AWM Investment Company Inc. purchased a new stake in CryoPort, Inc. (NASDAQ:CYRX - Free Report) in the second quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor purchased 61,111 shares of the company's stock, valued at approximately $959,000. AWM Investment Company Inc. owned about 0.12% of CryoPort at the end of the most recent reporting period.

A number of other institutional investors and hedge funds also recently modified their holdings of the stock. LPL Financial LLC increased its stake in CryoPort by 6.6% in the fourth quarter. LPL Financial LLC now owns 23,306 shares of the company's stock valued at $224,000 after purchasing an additional 1,433 shares in the last quarter. The Manufacturers Life Insurance Company boosted its position in shares of CryoPort by 9.4% during the second quarter. The Manufacturers Life Insurance Company now owns 18,178 shares of the company's stock worth $136,000 after purchasing an additional 1,557 shares in the last quarter. State of Wyoming boosted its position in shares of CryoPort by 30.2% during the second quarter. State of Wyoming now owns 14,218 shares of the company's stock worth $106,000 after purchasing an additional 3,301 shares in the last quarter. Basepoint Wealth LLC bought a new position in shares of CryoPort during the fourth quarter worth $34,000. Finally, BNP Paribas Financial Markets grew its holdings in shares of CryoPort by 55.2% in the 3rd quarter. BNP Paribas Financial Markets now owns 11,880 shares of the company's stock valued at $113,000 after buying an additional 4,225 shares during the period. 92.90% of the stock is owned by institutional investors.

CryoPort Trading Up 2.3%

Shares of CYRX stock opened at $16.72 on Wednesday. The firm's fifty day moving average price is $15.58 and its two-hundred day moving average price is $12.40. CryoPort, Inc. has a 1 year low of $7.61 and a 1 year high of $17.20. The firm has a market capitalization of $846.87 million, a P/E ratio of -18.58 and a beta of 1.89.

CryoPort (NASDAQ:CYRX - Get Free Report) last released its quarterly earnings data on Thursday, August 6th. The company reported ($0.20) EPS for the quarter, missing the consensus estimate of ($0.19) by ($0.01). CryoPort had a negative net margin of 20.05% and a negative return on equity of 7.20%. The company had revenue of $48.97 million during the quarter, compared to analyst estimates of $48.18 million. As a group, equities research analysts forecast that CryoPort, Inc. will post -0.83 EPS for the current fiscal year.

Insider Activity

In other news, CEO Jerrell Shelton sold 28,800 shares of the business's stock in a transaction dated Tuesday, August 11th. The shares were sold at an average price of $14.91, for a total transaction of $429,408.00. Following the transaction, the chief executive officer directly owned 1,201,814 shares in the company, valued at $17,919,046.74. The trade was a 2.34% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Director Ramkumar Mandalam sold 23,214 shares of the business's stock in a transaction dated Monday, June 8th. The stock was sold at an average price of $15.44, for a total transaction of $358,424.16. Following the transaction, the director owned 67,894 shares in the company, valued at $1,048,283.36. This represents a 25.48% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. In the last 90 days, insiders sold 256,441 shares of company stock worth $4,051,923. Insiders own 9.50% of the company's stock.

Analyst Ratings Changes

Several research analysts have weighed in on the company. BTIG Research lifted their target price on CryoPort from $17.00 to $25.00 and gave the stock a "buy" rating in a report on Friday, July 24th. Weiss Ratings lowered CryoPort from a "hold (c-)" rating to a "sell (d)" rating in a research report on Monday, August 17th. KeyCorp lifted their price objective on CryoPort from $15.00 to $17.00 and gave the company an "overweight" rating in a report on Wednesday, May 20th. Needham & Company LLC boosted their price objective on CryoPort from $15.00 to $19.00 and gave the company a "buy" rating in a research report on Friday, August 7th. Finally, Wall Street Zen raised CryoPort from a "sell" rating to a "hold" rating in a research note on Monday, May 11th. Seven analysts have rated the stock with a Buy rating, one has issued a Hold rating and one has given a Sell rating to the company. Based on data from MarketBeat.com, the company presently has an average rating of "Moderate Buy" and an average price target of $18.00.

CryoPort Profile

CryoPort, Inc NASDAQ: CYRX is a global provider of temperature-controlled logistics solutions for the life sciences industry. The company specializes in cryogenic shipping for critical biological materials, supporting the development, clinical testing and commercialization of cell and gene therapies, biologics, vaccines and reproductive medicine. By offering end-to-end supply chain management, CryoPort helps ensure the integrity and viability of temperature-sensitive products from point of origin to destination.

CryoPort's product portfolio includes proprietary cryogenic dry shippers, advanced active and passive thermal packaging, and real-time data monitoring platforms.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.